Mural Oncology Stock Discussion

$Mural Oncology (MURA.US)$
NEWS
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
Mural Oncology presented data from its ARTISTRY-3 trial at the ASCO annual meeting, showing that less frequent dosing of nemvaleukin alfa (nemvaleukin), an engineered IL-2 cytokine, is well-tolerated and effective.
The trial shifted from five daily infusions to two infusions per three-week cycle, both as a single agent and in combination with pembrolizu...

$Mural Oncology (MURA.US)$
NEWS
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting

$Mural Oncology (MURA.US)$ how do you circuit-break on 30cents,.

$Mural Oncology (MURA.US)$ Ride it hard! both up and down 🙂

$Mural Oncology (MURA.US)$ is this dead? no vol and dipping

👁️ 👁️
  👃
  👄
$Mural Oncology (MURA.US)$

$Mural Oncology (MURA.US)$ bears are leaving, closed my short and locked profits!